Literature DB >> 21739448

Molecular determinants of disease in coxsackievirus B1 murine infection.

Javier O Cifuente1, María F Ferrer, Carolina Jaquenod de Giusti, Wen-Chao Song, Víctor Romanowski, Susan L Hafenstein, Ricardo M Gómez.   

Abstract

To understand better how different genomic regions may confer pathogenicity for the coxsackievirus B (CVB), two intratypic CVB1 variants, and a number of recombinant viruses were studied. Sequencing analysis showed 23 nucleotide changes between the parental non-pathogenic CVB1N and the pathogenic CVB1Nm. Mutations present in CVB1Nm were more conserved than those in CVB1N when compared to other CVB sequences. Inoculation in C3H/HeJ mice showed that the P1 region is critical for pathogenicity in murine pancreas and heart. The molecular determinants of disease for these organs partially overlap. Several P1 region amino acid differences appear to be located in the decay-accelerating factor (DAF) footprint CVBs. CVB1N and CVB1Nm interacted with human CAR, but only CVB1N seemed to interact with human DAF, as determined using soluble receptors in a plaque-reduction assay. However, the murine homolog Daf-1 did not interact with any virus assessed by hemagglutination. The results of this study suggest that an unknown receptor interaction with the virus play an important role in the pathogenicity of CVB1Nm. Further in vivo studies may clarify this issue.
Copyright © 2011 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21739448      PMCID: PMC3677187          DOI: 10.1002/jmv.22133

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  71 in total

1.  Interpretation of electron density with stereographic roadmap projections.

Authors:  Chuan Xiao; Michael G Rossmann
Journal:  J Struct Biol       Date:  2006-10-24       Impact factor: 2.867

2.  COBALT: constraint-based alignment tool for multiple protein sequences.

Authors:  Jason S Papadopoulos; Richa Agarwala
Journal:  Bioinformatics       Date:  2007-03-01       Impact factor: 6.937

3.  Coxsackieviruses B1, B3, and B5 use decay accelerating factor as a receptor for cell attachment.

Authors:  D R Shafren; R C Bates; M V Agrez; R L Herd; G F Burns; R D Barry
Journal:  J Virol       Date:  1995-06       Impact factor: 5.103

4.  Reduced surface: an efficient way to compute molecular surfaces.

Authors:  M F Sanner; A J Olson; J C Spehner
Journal:  Biopolymers       Date:  1996-03       Impact factor: 2.505

5.  A mutation in the puff region of VP2 attenuates the myocarditic phenotype of an infectious cDNA of the Woodruff variant of coxsackievirus B3.

Authors:  K U Knowlton; E S Jeon; N Berkley; R Wessely; S Huber
Journal:  J Virol       Date:  1996-11       Impact factor: 5.103

6.  CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice.

Authors:  J D Thompson; D G Higgins; T J Gibson
Journal:  Nucleic Acids Res       Date:  1994-11-11       Impact factor: 16.971

7.  Theiler's murine encephalomyelitis virus-induced cardiac and skeletal muscle disease.

Authors:  R M Gómez; J E Rinehart; R Wollmann; R P Roos
Journal:  J Virol       Date:  1996-12       Impact factor: 5.103

8.  The structure of coxsackievirus B3 at 3.5 A resolution.

Authors:  J K Muckelbauer; M Kremer; I Minor; G Diana; F J Dutko; J Groarke; D C Pevear; M G Rossmann
Journal:  Structure       Date:  1995-07-15       Impact factor: 5.006

9.  Coxsackievirus B3 adapted to growth in RD cells binds to decay-accelerating factor (CD55).

Authors:  J M Bergelson; J G Mohanty; R L Crowell; N F St John; D M Lublin; R W Finberg
Journal:  J Virol       Date:  1995-03       Impact factor: 5.103

Review 10.  Viral cell recognition and entry.

Authors:  M G Rossmann
Journal:  Protein Sci       Date:  1994-10       Impact factor: 6.725

View more
  9 in total

1.  The crystal structure of a coxsackievirus B3-RD variant and a refined 9-angstrom cryo-electron microscopy reconstruction of the virus complexed with decay-accelerating factor (DAF) provide a new footprint of DAF on the virus surface.

Authors:  Joshua D Yoder; Javier O Cifuente; Jieyan Pan; Jeffrey M Bergelson; Susan Hafenstein
Journal:  J Virol       Date:  2012-09-12       Impact factor: 5.103

2.  Molecular Communications in Viral Infections Research: Modeling, Experimental Data, and Future Directions.

Authors:  Michael Taynnan Barros; Mladen Veletic; Masamitsu Kanada; Massimiliano Pierobon; Seppo Vainio; Ilangko Balasingham; Sasitharan Balasubramaniam
Journal:  IEEE Trans Mol Biol Multiscale Commun       Date:  2021-04-15

Review 3.  Unresolved issues in theories of autoimmune disease using myocarditis as a framework.

Authors:  Robert Root-Bernstein; DeLisa Fairweather
Journal:  J Theor Biol       Date:  2014-12-04       Impact factor: 2.691

4.  Human Gut-On-A-Chip Supports Polarized Infection of Coxsackie B1 Virus In Vitro.

Authors:  Remi Villenave; Samantha Q Wales; Tiama Hamkins-Indik; Efstathia Papafragkou; James C Weaver; Thomas C Ferrante; Anthony Bahinski; Christopher A Elkins; Michael Kulka; Donald E Ingber
Journal:  PLoS One       Date:  2017-02-01       Impact factor: 3.240

Review 5.  Development of Group B Coxsackievirus as an Oncolytic Virus: Opportunities and Challenges.

Authors:  Huitao Liu; Honglin Luo
Journal:  Viruses       Date:  2021-06-05       Impact factor: 5.048

6.  Effects of heat stress on the expression of the coxsackievirus and adenovirus receptor in mouse skin keratinocytes.

Authors:  Xiangdong Deng; Chiyu Jia; Fuxing Chen; Junquan Liu; Zonghai Zhou
Journal:  Exp Ther Med       Date:  2013-07-23       Impact factor: 2.447

7.  The whole genome sequence of coxsackievirus B3 MKP strain leading to myocarditis and its molecular phylogenetic analysis.

Authors:  Bin Liu; Zhe Li; Fengyang Xiang; Fan Li; Yang Zheng; Guoqing Wang
Journal:  Virol J       Date:  2014-02-21       Impact factor: 4.099

8.  Rethinking Molecular Mimicry in Rheumatic Heart Disease and Autoimmune Myocarditis: Laminin, Collagen IV, CAR, and B1AR as Initial Targets of Disease.

Authors:  Robert Root-Bernstein
Journal:  Front Pediatr       Date:  2014-08-19       Impact factor: 3.418

Review 9.  Human Organs-on-Chips for Virology.

Authors:  Huaqi Tang; Yasmine Abouleila; Longlong Si; Ana Maria Ortega-Prieto; Christine L Mummery; Donald E Ingber; Alireza Mashaghi
Journal:  Trends Microbiol       Date:  2020-07-13       Impact factor: 17.079

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.